- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 78.91 | 17.48 | 51.0 | 2.11 | 18.54 | -15.6 | 5.35 | 19.15 | 28.92 | 0 | 0 | 0 | 2.67 | 0.9 | -44.1 | 6.78 | 1.43 | -14.62 | 0.00 | 0 | 0 | 0 | 0 | 0 |
24Q2 (19) | 67.17 | 19.26 | 28.31 | 1.78 | -1.66 | 2.89 | 4.49 | -2.39 | -2.6 | 0 | 0 | 0 | 2.65 | -17.54 | -19.81 | 6.68 | -18.16 | -24.09 | 0.00 | 0 | 0 | 0 | 0 | 0 |
24Q1 (18) | 56.32 | -8.66 | 3.99 | 1.81 | -47.99 | 1.69 | 4.6 | -5.54 | 1.55 | 0 | 0 | 0 | 3.21 | -43.06 | -2.21 | 8.17 | 3.41 | -2.35 | 0.00 | 0 | 0 | 0 | 0 | 0 |
23Q4 (17) | 61.66 | 17.99 | -21.64 | 3.48 | 39.2 | -13.43 | 4.87 | 17.35 | -16.18 | 0 | 0 | 0 | 5.64 | 17.98 | 10.48 | 7.90 | -0.54 | 6.97 | 0.00 | 0 | 0 | 0 | 0 | 0 |
23Q3 (16) | 52.26 | -0.17 | -49.6 | 2.5 | 44.51 | -21.38 | 4.15 | -9.98 | -33.81 | 0 | 0 | 0 | 4.78 | 44.76 | 55.98 | 7.94 | -9.82 | 31.33 | 0.00 | 0 | 0 | 0 | 0 | 0 |
23Q2 (15) | 52.35 | -3.34 | -54.7 | 1.73 | -2.81 | 1.17 | 4.61 | 1.77 | -3.56 | 0 | 0 | 0 | 3.30 | 0.55 | 123.33 | 8.81 | 5.28 | 112.89 | 0.00 | 0 | 0 | 0 | 0 | 0 |
23Q1 (14) | 54.16 | -31.17 | -52.41 | 1.78 | -55.72 | -12.32 | 4.53 | -22.03 | -20.8 | 0 | 0 | 0 | 3.29 | -35.67 | 84.26 | 8.36 | 13.28 | 66.42 | 0.00 | 0 | 0 | 0 | 0 | 0 |
22Q4 (13) | 78.69 | -24.11 | -41.33 | 4.02 | 26.42 | -12.8 | 5.81 | -7.34 | -27.28 | 0 | 0 | 0 | 5.11 | 66.58 | 48.63 | 7.38 | 22.1 | 23.94 | 0.00 | 0 | 0 | 0 | 0 | 0 |
22Q3 (12) | 103.69 | -10.27 | 3.57 | 3.18 | 85.96 | 70.05 | 6.27 | 31.17 | 26.16 | 0 | 0 | 0 | 3.07 | 107.25 | 64.2 | 6.05 | 46.19 | 21.81 | 0.00 | 0 | 0 | 0 | 0 | 0 |
22Q2 (11) | 115.56 | 1.54 | 34.65 | 1.71 | -15.76 | 12.5 | 4.78 | -16.43 | 13.0 | 0 | 0 | 0 | 1.48 | -17.04 | -16.45 | 4.14 | -17.7 | -16.08 | 0.00 | 0 | 0 | 0 | 0 | 0 |
22Q1 (10) | 113.81 | -15.14 | 63.03 | 2.03 | -55.97 | 13.41 | 5.72 | -28.41 | 44.44 | 0 | 0 | 0 | 1.78 | -48.11 | -30.44 | 5.03 | -15.63 | -11.4 | 0.00 | 0 | 0 | 0 | 0 | 0 |
21Q4 (9) | 134.12 | 33.96 | 117.59 | 4.61 | 146.52 | 80.78 | 7.99 | 60.76 | 62.07 | 0 | 0 | 0 | 3.44 | 84.03 | -16.91 | 5.96 | 20.01 | -25.51 | 0.00 | 0 | 0 | 0 | 0 | 0 |
21Q3 (8) | 100.12 | 16.66 | 78.91 | 1.87 | 23.03 | 19.11 | 4.97 | 17.49 | 18.62 | 0 | 0 | 0 | 1.87 | 5.45 | -33.43 | 4.96 | 0.71 | -33.7 | 0.00 | 0 | 0 | 0 | 0 | 0 |
21Q2 (7) | 85.82 | 22.93 | 21.99 | 1.52 | -15.08 | -10.06 | 4.23 | 6.82 | -8.04 | 0 | 0 | 0 | 1.77 | -30.93 | -26.27 | 4.93 | -13.11 | -24.62 | 0.00 | 0 | 0 | 0 | 0 | 0 |
21Q1 (6) | 69.81 | 13.25 | 68.1 | 1.79 | -29.8 | 6.55 | 3.96 | -19.68 | 3.39 | 0 | 0 | 0 | 2.56 | -38.02 | -36.61 | 5.67 | -29.08 | -38.49 | 0.00 | 0 | 0 | 0 | 0 | 0 |
20Q4 (5) | 61.64 | 10.15 | 27.09 | 2.55 | 62.42 | 44.89 | 4.93 | 17.66 | -5.92 | 0 | 0 | 0 | 4.14 | 47.45 | 14.0 | 8.00 | 6.82 | -25.97 | 0.00 | 0 | 0 | 0 | 0 | 0 |
20Q3 (4) | 55.96 | -20.45 | 0.0 | 1.57 | -7.1 | 0.0 | 4.19 | -8.91 | 0.0 | 0 | 0 | 0.0 | 2.81 | 16.79 | 0.0 | 7.49 | 14.51 | 0.0 | 0.00 | 0 | 0.0 | 0 | 0 | 0.0 |
20Q2 (3) | 70.35 | 69.4 | 0.0 | 1.69 | 0.6 | 0.0 | 4.6 | 20.1 | 0.0 | 0 | 0 | 0.0 | 2.40 | -40.62 | 0.0 | 6.54 | -29.1 | 0.0 | 0.00 | 0 | 0.0 | 0 | 0 | 0.0 |
20Q1 (2) | 41.53 | -14.37 | 0.0 | 1.68 | -4.55 | 0.0 | 3.83 | -26.91 | 0.0 | 0 | 0 | 0.0 | 4.05 | 11.47 | 0.0 | 9.22 | -14.64 | 0.0 | 0.00 | 0 | 0.0 | 0 | 0 | 0.0 |
19Q4 (1) | 48.5 | 0.0 | 0.0 | 1.76 | 0.0 | 0.0 | 5.24 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 3.63 | 0.0 | 0.0 | 10.80 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 220.43 | -46.47 | 9.49 | -13.33 | 18.16 | -19.57 | 0 | 0 | 4.31 | 61.89 | 8.24 | 50.23 | 0.00 | 0 | 0 | 0 |
2022 (9) | 411.75 | 5.61 | 10.95 | 11.85 | 22.58 | 6.71 | 0 | 0 | 2.66 | 5.91 | 5.48 | 1.04 | 0.00 | 0 | 0 | 0 |
2021 (8) | 389.87 | 69.89 | 9.79 | 30.53 | 21.16 | 20.64 | 0 | 0 | 2.51 | -23.16 | 5.43 | -28.99 | 0.00 | 0 | 0 | 0 |
2020 (7) | 229.49 | 28.91 | 7.5 | 0.54 | 17.54 | 2.39 | 0 | 0 | 3.27 | -22.01 | 7.64 | -20.57 | 0.00 | 0 | 0 | 0 |
2019 (6) | 178.03 | -3.48 | 7.46 | 11.18 | 17.13 | 9.81 | 0 | 0 | 4.19 | 15.18 | 9.62 | 13.76 | 0.00 | 0 | 0 | 0 |
2018 (5) | 184.44 | 5.2 | 6.71 | 7.7 | 15.6 | 1.04 | 0 | 0 | 3.64 | 2.38 | 8.46 | -3.95 | 0.00 | 0 | 0 | 0 |
2017 (4) | 175.33 | 8.51 | 6.23 | -1.58 | 15.44 | -1.59 | 0 | 0 | 3.55 | -9.3 | 8.81 | -9.31 | 0.00 | 0 | 0 | 0 |
2016 (3) | 161.58 | 3.92 | 6.33 | -3.36 | 15.69 | 2.35 | 0 | 0 | 3.92 | -7.0 | 9.71 | -1.51 | 0.00 | 0 | 1834 | 0.0 |
2015 (2) | 155.49 | -8.44 | 6.55 | 5.14 | 15.33 | 5.43 | 0 | 0 | 4.21 | 14.83 | 9.86 | 15.16 | 0.00 | 0 | 1834 | 0.0 |
2014 (1) | 169.83 | 19.83 | 6.23 | 5.59 | 14.54 | 5.67 | 0 | 0 | 3.67 | 0 | 8.56 | 0 | 0.00 | 0 | 1834 | 0.0 |